Update On Board Investigation and Interims Date

AI SummaryClose X

SkinBioTherapeutics plc expects its shares to be suspended from trading on April 1, 2026, due to a delay in publishing its interim results for the six months ended December 31, 2025, which are contingent on an ongoing Board investigation. The company reported a robust cash position of £2.44 million as of March 19, 2026, and its businesses are operating as usual. Trading is anticipated to resume once the investigation concludes and the interim results are released.

Disclaimer*

UK 100

Latest directors dealings